Abbott Receives FDA Approval for Molecular Test for Hepatitis C

Abbott ABT announced today that it has received approval from the U.S. Food and Drug Administration to market its RealTime PCR test for measuring the viral load of hepatitis C, the leading cause of liver cancer in the United States.